Pre-mercato: 3.24

Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals Inc Borsa (AMLX) Ultime notizie

Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals Inc Borsa (AMLX) Ultime notizie

Amylyx Pharmaceuticals Navigates Shift to Smaller Reporting Status: Impacts on Investor Relations and Stock Volatility - TipRanks

Amyotrophic Lateral Sclerosis Treatment Market is Booming with - openPR

Almitas Capital LLC Makes New Investment in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat

XTX Topco Ltd Purchases New Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat

Ratio Analysis: Unpacking America Movil S.A.B.DE C.V. ADR (AMX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Alpha Metallurgical Resources (NYSE:AMR) Shares Up 8.1% - MarketBeat

A year in review: Amylyx Pharmaceuticals Inc (AMLX)’s performance in the last year - US Post News

Insider Sale Alert: Aldeyra Therapeutics Inc [ALDX] – Is it Time to sell? - Knox Daily

A Guide To The Risks Of Investing In Amylyx Pharmaceuticals Inc (AMLX) - Knox Daily

Get in on Aldeyra Therapeutics Inc’s (ALDX) buy-in window today! - SETE News

Acadian Asset Management LLC Purchases Shares of 7,699 Amcor plc (NYSE:AMCR) - Defense World

Meiji Yasuda Life Insurance Co Boosts Holdings in Amcor plc (NYSE:AMCR) - Defense World

AMLX’s Stock Journey: What Investors Need to Know About Amylyx Pharmaceuticals Inc’s Performance - The InvestChronicle

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Stock Catapults 37% Though Its Price And Business Still Lag The Industry - Simply Wall St

Taking a Closer Look At Amarin Corp ADR (AMRN) Following Its Recent Trade - Knox Daily

Amylyx Pharmaceuticals Inc (AMLX)’s Market Momentum: Closing Strong at 2.65, Up 1.15 - The Dwinnex

Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying - Benzinga

Examining Amylyx Pharmaceuticals Inc (AMLX) stock is warranted - US Post News

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) CFO James M. Frates Purchases 40,000 Shares - Defense World

Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm - ForexTV.com

Does Amylyx Pharmaceuticals Inc (AMLX) offer a good opportunity for investors? - SETE News

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Short Interest Update - MarketBeat

Acadian Asset Management LLC Purchases New Position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Amylyx pharmaceuticals director buys $106,590 in stock - Investing.com

Amylyx pharmaceuticals director buys $106,590 in stock - Investing.com India

Director Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX) - Yahoo Finance

Director Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX) By GuruFocus - Investing.com Canada

Amylyx Pharmaceuticals: Management Ambitiously Navigates Challenges (NASDAQ:AMLX) - Seeking Alpha

Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 - Marketscreener.com

Director MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX) - Yahoo Finance

Director MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX) By GuruFocus - Investing.com Canada

Amylyx Pharmaceuticals director buys $219,800 in stock - Investing.com India

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Director Purchases $220,000.00 in Stock - MarketBeat

Amylyx Pharmaceuticals director buys $219,800 in stock - Investing.com

Amylyx Pharmaceuticals director buys $219,800 in stock By Investing.com - Investing.com UK

Amyotrophic Lateral Sclerosis Market to Show Remarkable Growth - openPR

Amyotrophic Lateral Sclerosis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Amylyx Pharma, Ionis Pharma, Annexon, Inc., UniQure Biopharma, Sangamo Therapeutics - Barchart

Investigation announced for Long-Term Investors in shares - openPR

Manufacturer to pull controversial ALS drug off the market after failed clinical trial - MSN

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Sees Significant Growth in Short Interest - MarketBeat

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - Elk Valley Times

Oral AMX0035 found to improve core Alzheimer’s-related biomarkers - Alzheimer's News Today

SG Americas Securities LLC Acquires 29,697 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - StockTitan

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - Manchestertimes

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

Amylyx Pharma pulls ALS drug from US market as it didn't help patients - MSN

Cwm LLC Raises Stock Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Rating of “Hold” from Brokerages - Defense World

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Short Interest Down 50.8% in July - MarketBeat

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Short Interest Down 50.8% in July - Defense World

Vanguard Group Inc. Boosts Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World

Amylyx Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and Neurodegeneration - Business Wire

We Think Amylyx Pharmaceuticals (NASDAQ:AMLX) Can Easily Afford To Drive Business Growth - Yahoo Finance

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q2 2024 Earnings Call Transcript - Insider Monkey

Earnings call: Amylyx Pharmaceuticals reports Q2 2024 financials By Investing.com - Investing.com Australia

Earnings call: Amylyx Pharmaceuticals reports Q2 2024 financials By Investing.com - Investing.com Canada

Earnings call: Amylyx Pharmaceuticals reports Q2 2024 financials - Investing.com

Earnings call: Amylyx Pharmaceuticals reports Q2 2024 financials - Investing.com India

Earnings call: Amylyx Pharmaceuticals reports Q2 2024 financials By Investing.com - Investing.com UK

Simile a AMLX